I would love to, but links to sites that make claims is treated as if we made the claims. The best I could do would be to maybe suggest that people search the net using Google for more information, and suggest search terms that would put your site at the top.
Marshall Jan Stoeten wrote: > Hello Marshall, > > Here, in the Netherlands, I will be setting up a website that should be up > and running by March 16th. We do not have an FDA or anything like it. It is > possible to make many health claims on your site in the Netherlands. I was > thinking of making MANY, MANY claims on my future site that will starting > off with the best and cheapest colloidal silver in our country. If there is > a way that your site (or those of others) could access (link to) my claims > without the FDA breathing down your neck, then I would be more than pleased > to be of any assistance. Let me know what you think. > > All the best, > Jan Stoeten, the Netherlands > > ----- Original Message ----- > From: "Marshall Dudley" <[email protected]> > To: <[email protected]> > Sent: Tuesday, February 17, 2004 3:50 PM > Subject: Re: CS>Emailing: ANS00971 > > > The FDA really gives the CS producers a catch 22. I wanted to include > some > > documentation that indicated that if one is chronically ill then they > should > > start off with small amounts of CS. This would be a warning to prevent one > from > > becoming very sick from a healing crisis. But I can't do that because > that says > > that CS kills pathogens, and then the FDA could come after me. So I am > unable to > > give a real warning to a real possible problem due to the FDA wanting the > people > > to not know that it works.. > > > > Go figure. > > > > Marshall > > > > Thora Rasmussen wrote: > > > > > It is my understanding that non drug products cannot make cure claims, > so > > > anything mentioning the actual way to use it would not be allowed. This > > > letter was trickily written. It actually does not say it is dangerous. > It > > > just says the limitations on labelling. I am unsure on what the US > rules > > > for dosage are, but I think what they are saying is that dosages need to > be > > > clearly marked. In Canada many things will have dosage recommendations > at a > > > level that will not harm anyone, but for those people doing their own > > > research, they will take however much they want. If necessary, warnings > can > > > also be included to indicate if, for example, a rash or stomache ache > occurs > > > to discontinue use. Here in Canada, there is no way you could possibly > > > figure out how to use products unless you obtained the information in a > > > different spot than the bottle. Here, those 2 things cannot legally > exist > > > together. That is why we often see one site with product info that does > not > > > really tell us how much to take and when. The light warning against > argyria > > > looks like just a scare tactic without actually lying. The abuse that > is > > > required to cause it is so way beyond even most radical users, but they > just > > > "gotta" throw that in there. Wouldn't it be interesting to see this > type of > > > warning on every drug, food, and OTC medicine. No one would leave there > > > house!! We'd all be scared to death!! > > > > > > Thora > > > > > > -----Original Message----- > > > From: bob smith [mailto:[email protected]] > > > Sent: Monday, February 16, 2004 2:33 PM > > > To: [email protected] > > > Subject: CS>Emailing: ANS00971 > > > > > > I just came across this article. I had never heard of these > restrictions on > > > CS. My understanding was that they did not find it harmful. But there > > > could be no claims made as to its benefits. Bob Smith > > > > > > FDA > > > TALK PAPER > > > Food and Drug Administration > > > U.S. Department of Health and Human Services > > > Public Health Service 5600 Fishers Lane Rockville, MD 20857 > > > > > > FDA Talk Papers are prepared by the Press Office to guide FDA personnel > in > > > responding with consistency and accuracy to questions from the public on > > > subjects of current interest. Talk Papers are subject to change as more > > > information becomes available. > > > > > > T99-39 Print Media: 301-827-6242 > > > August 17, 1999 > > > Consumer Inquiries: 888-INFO-FDA > > > > > > FDA ISSUES FINAL RULE ON > > > OTC DRUG PRODUCTS CONTAINING COLLOIDAL SILVER > > > The FDA has issued a Final Rule declaring that all over- the-counter > (OTC) > > > drug products containing colloidal silver or silver salts are not > recognized > > > as safe and effective and are misbranded. > > > Colloidal silver is a suspension of silver particles in a colloidal > > > (gelatinous) base. In recent years, colloidal silver preparations of > unknown > > > formulation have been appearing in stores. These products are labeled to > > > treat adults and children for diseases including HIV, AIDS, cancer, > > > tuberculosis, malaria, lupus, syphilis, scarlet fever, shingles, herpes, > > > pneumonia, typhoid, tetanus and many others. > > > According to the Final Rule, a colloidal silver product for any drug use > > > will first have to be approved by FDA under the new drug application > > > procedures. The Final rule classifies colloidal silver products as > > > misbranded because adequate directions cannot be written so that the > general > > > public can use these drugs safely for their intended purposes. They are > also > > > misbranded when their labeling falsely suggests that there is > substantial > > > scientific evidence to establish that the drugs are safe and effective > for > > > their intended uses. > > > The indiscriminate use of colloidal silver solutions has resulted in > cases > > > of argyria, a permanent blue-gray discoloration of the skin and deep > > > tissues. > > > Colloidal silver ingredients and silver salts include silver proteins, > mild > > > silver protein, strong silver protein, silver chloride, and silver > iodide. > > > The dosage form of these colloidal silver products is usually oral, but > > > product labeling also contains directions for topical and, occasionally, > > > intravenous use. > > > In reaching its decision, FDA considered all of the information > described in > > > the proposed rule (October 15, 1996) and submitted by the public in > response > > > to that proposal, the Final Rule becomes effective on September 16, > 1999, 30 > > > days after publication. > > > #### > > > > > > -- > > > The Silver List is a moderated forum for discussing Colloidal Silver. > > > > > > Instructions for unsubscribing are posted at: http://silverlist.org > > > > > > To post, address your message to: [email protected] > > > Silver List archive: http://escribe.com/health/thesilverlist/index.html > > > > > > Address Off-Topic messages to: [email protected] > > > OT Archive: http://escribe.com/health/silverofftopiclist/index.html > > > > > > List maintainer: Mike Devour <[email protected]> > > > > > > -- > > The Silver List is a moderated forum for discussing Colloidal Silver. > > > > Instructions for unsubscribing are posted at: http://silverlist.org > > > > To post, address your message to: [email protected] > > Silver List archive: http://escribe.com/health/thesilverlist/index.html > > > > Address Off-Topic messages to: [email protected] > > OT Archive: http://escribe.com/health/silverofftopiclist/index.html > > > > List maintainer: Mike Devour <[email protected]> > > > > > > -- > The Silver List is a moderated forum for discussing Colloidal Silver. > > Instructions for unsubscribing are posted at: http://silverlist.org > > To post, address your message to: [email protected] > Silver List archive: http://escribe.com/health/thesilverlist/index.html > > Address Off-Topic messages to: [email protected] > OT Archive: http://escribe.com/health/silverofftopiclist/index.html > > List maintainer: Mike Devour <[email protected]> -- The Silver List is a moderated forum for discussing Colloidal Silver. Instructions for unsubscribing are posted at: http://silverlist.org To post, address your message to: [email protected] Silver List archive: http://escribe.com/health/thesilverlist/index.html Address Off-Topic messages to: [email protected] OT Archive: http://escribe.com/health/silverofftopiclist/index.html List maintainer: Mike Devour <[email protected]>
